BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12689736)

  • 1. Assessing treatment efficacy in noninferiority trials.
    Wang SJ; Hung HM
    Control Clin Trials; 2003 Apr; 24(2):147-55. PubMed ID: 12689736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the lower predictive bound approach for noninferiority clinical trials with binary data.
    Liu Q; Li Y
    J Biopharm Stat; 2014; 24(6):1225-38. PubMed ID: 25036815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoiding ambiguity with the Type I error rate in noninferiority trials.
    Kang SH
    J Biopharm Stat; 2016; 26(3):452-65. PubMed ID: 26252624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
    Hida E; Tango T
    J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive designs for noninferiority trials.
    Gao P; Liu L; Mehta C
    Biom J; 2013 May; 55(3):310-21. PubMed ID: 23494872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotheses and type I error in active-control noninferiority trials.
    Chen G; Wang YC; Chi GY
    J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
    Sankoh AJ
    Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bootstrap-based test for establishing noninferiority in clinical trials.
    Chen M; Kianifard F; Dhar SK
    J Biopharm Stat; 2006 May; 16(3):357-63. PubMed ID: 16724490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and analysis of a 3-arm noninferiority trial with a prespecified margin for the hazard ratio.
    Hida E; Tango T
    Pharm Stat; 2018 Sep; 17(5):489-503. PubMed ID: 29984524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical issues on objective, design, and analysis of noninferiority active-controlled clinical trial.
    Tsong Y; Wang SJ; Hung HM; Cui L
    J Biopharm Stat; 2003 Feb; 13(1):29-41. PubMed ID: 12635901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian approach for assessing noninferiority in a three-arm trial with binary endpoint.
    Ghosh S; Tiwari RC; Ghosh S
    Pharm Stat; 2018 Jul; 17(4):342-357. PubMed ID: 29473291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y; Chen WJ
    J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good enough: a primer on the analysis and interpretation of noninferiority trials.
    Kaul S; Diamond GA
    Ann Intern Med; 2006 Jul; 145(1):62-9. PubMed ID: 16818930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility and pitfalls of some statistical methods in active controlled clinical trials.
    Wang SJ; Hung HM; Tsong Y
    Control Clin Trials; 2002 Feb; 23(1):15-28. PubMed ID: 11852161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test Statistics and Confidence Intervals to Establish Noninferiority between Treatments with Ordinal Categorical Data.
    Zhang F; Miyaoka E; Huang F; Tanaka Y
    J Biopharm Stat; 2015; 25(5):921-38. PubMed ID: 24919157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.